Search Within

Matthew G Fury

Formats
  1. Journal Article (57)
  2. Meeting Abstract (42)
  3. Book Section (2)
  4. Book Whole (1)
Groups
  1. Department of Medicine (93)
  2. Solid Tumor Oncology Division (93)
  3. Head and Neck Service (81)
  4. Radiology, Department of (53)
  5. Surgery (46)
  6. Head and Neck Surgery (42)

More Groups

People
  1. David Pfister (69)
  2. Eric Sherman (52)
  3. Nancy Lee (41)
  4. Sofia Haque (29)
  5. Alan Ho (26)
  6. Nora Katabi (20)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (1)
  5. 2017 (5)
  6. 2016 (3)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. International Journal of Radiation Oncology, Biology, Physics (19)
  3. Cancer Chemotherapy and Pharmacology (6)
  4. Cancer (5)
  5. Annals of Oncology (3)
  6. Head & Neck (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Elsevier Inc. (29)
  3. Springer (10)
  4. Wiley Blackwell (6)
  5. Harborside Press (3)
  6. John Wiley & Sons, Inc. (3)

More Publishers

Results (102)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m(2) for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Lisa, D. M.; Agarwal, N.; Algazy, K. M.; Brockstein, B.; Langer, C. J.; Lim, D.; Mehra, R.; Rajan, S. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: A critical re-evaluation including uniform pathologic review
    Journal Article

    Sherman, E. J.; Lim, S. H.; Ho, A. L.; Ghossein, R. A.; Fury, M. G.; Shaha, A. R.; Rivera, M.; Lin, O.; Wolden, S.; Lee, N. Y.; more...
    Radiotherapy and Oncology (2011)

    Fulltext@MSK | Save
  • Subjective hearing loss (SHL) after chemoradiation for nasopharyngeal and oropharyngeal cancer patients
    Meeting Abstract

    Rao, S. S.; Jackson, A.; Ming, L.; Setton, J.; Fong, B. T.; Wolden, S.; Fury, M. G.; Sherman, E. J.; Pfister, D. G.; Lee, N. Y.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer
    Meeting Abstract

    Morris, L.; Goenka, A.; Rao, S.; Wolden, S.; Ganly, I.; Wong, R.; Kraus, D.; Fury, M.; Zelefsky, M.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • A pilot study of using pre- and early (1 week) [18f]-misonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) scans as an early treatment response predictor in a series of head and neck cancer (HNC) patients undergoing chemoradiation
    Meeting Abstract

    Lee, N.; Bartlett, R.; Lian, M.; Fury, M.; Sherman, E.; Wong, R.; Zanzonico, P. B.; Schoder, H.; Humm, J.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer
    Journal Article

    Koutcher, L.; Sherman, E.; Fury, M.; Wolden, S.; Zhang, Z.; Mo, Q.; Stewart, L.; Schupak, K.; Gelblum, D.; Wong, R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
    Journal Article

    Laurie, S. A.; Ho, A. L.; Fury, M. G.; Sherman, E.; Pfister, D. G.
    Lancet Oncology (2011)

    Fulltext@MSK | Save
  • Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma
    Journal Article

    Fury, M. G.; Drobnjak, M.; Sima, C. S.; Asher, M.; Shah, J.; Lee, N.; Carlson, D.; Wendel, H. G.; Pfister, D. G.
    Head & Neck (2011)

    Fulltext@MSK | Save
  • Current recommendations for systemic therapy of recurrent and/or metastatic head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Pfister, D. G.
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save
  • A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Haque, S.; Stambuk, H.; Shen, R.; Carlson, D.; Pfister, D.
    Cancer (2011)

    Fulltext@MSK | Save